In patients with inflammatory bowel disease, spondyloarthritis, and multiple sclerosis, IgA responses to specific intestinal bacteria are associated with disease severity (Palm et al., 2014; Gill et al., 2022; Gupta et al., 2025). Here, CD79A is linked to spondyloarthropathy.